Cochlear Limited (ASX:COH)
182.42
+2.25 (1.25%)
Mar 10, 2026, 12:19 PM AEST
Cochlear Revenue
Cochlear had revenue of 1.17B AUD in the half year ending December 31, 2025, with 6.25% growth. This brings the company's revenue in the last twelve months to 2.34B, up 1.28% year-over-year. In the fiscal year ending June 30, 2025, Cochlear had annual revenue of 2.34B with 4.81% growth.
Revenue (ttm)
2.34B
Revenue Growth
+1.28%
P/S Ratio
5.04
Revenue / Employee
425.18K
Employees
5,500
Market Cap
11.78B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 2.34B | 107.50M | 4.81% |
| Jun 30, 2024 | 2.24B | 299.50M | 15.47% |
| Jun 30, 2023 | 1.94B | 287.80M | 17.46% |
| Jun 30, 2022 | 1.65B | 150.70M | 10.06% |
| Jun 30, 2021 | 1.50B | 177.00M | 13.40% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| 4DMedical | 5.81M |
| Anteris Technologies Global | 2.87M |
| PolyNovo | 139.49M |
| Lumos Diagnostics Holdings | 18.31M |
| Aroa Biosurgery | 79.26M |
| Epiminder | 648.18K |
| EMVision Medical Devices | 5.43M |
| SomnoMed | 118.50M |
Cochlear News
- 12 days ago - Cochlear implant done on 3-year-old - The Times of India
- 12 days ago - Cochlear North America Celebrates International Cochlear Implant Day with Announcement of 2026 Academic Scholarship Recipients - PRNewsWire
- 24 days ago - Cochlear Limited (CHEOY) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 24 days ago - Cochlear CEO: AUD currency fluctuations weighing on earnings - CNBC
- 24 days ago - Cochlear Ltd (CHEOF) (Half Year 2026) Earnings Call Highlights: Navigating Challenges and ... - GuruFocus
- 24 days ago - Half Year 2026 Cochlear Ltd Earnings Call Transcript - GuruFocus
- 25 days ago - Cochlear lowers guidance after delays to new implant rollout - The Australian Financial Review
- 25 days ago - Cochlear shares hit three-year low on new implant delays - The Australian Financial Review